Erweiterte Suche

Yusuf Khwaja Hamied ist Non-Executive Chairman bei Cipla Ltd. und Chairman bei Cipla Medpro Pty Ltd. (eine Tochtergesellschaft von Cipla Ltd.). Er erhielt einen Doktortitel von der Universität Cambridge.

Khwaja Abdul Hamied is the founder of Cipla Ltd.
and Cipla BioTec Ltd., both founded in 1935.

Mustafa Khwaja Hamied ist Mitglied des Vorstands von Cipla Ltd. (ehemaliger Executive Vice Chairman). Er erwarb einen Bachelor-Abschluss an der Universität von Mumbai.

Khalid Hamied was the founder of Optimi Corp.
which was founded in 2003 where he held the titles of President & Chief Technology Officer.
He previously worked as a Lead Engineer at Motorola, Inc., a Principal Engineer at MSK2 LLC, and a Senior Staff Engineer at Motorola Labs, Inc. Dr. Hamied received a doctorate degree from Georgia Institute of Technology in 1994.

Imtiaz Ahmed Khwaja is currently the Chief Executive Officer, MD & Executive Director at Leiner Pak Gelatine Ltd.
since 2010 and the Director at B.P.
Lahore (Pvt) Ltd.
since 2013.
He previously worked as a Director at The Lahore Stock Exchange (Guarantee) Ltd.
Mr. Khwaja completed his undergraduate degree at Hailey College of Commerce.

Shawez Khwaja currently works as a trustee at Lichfield Garrick Theatre.

Omar Khwaja currently works at Korro Bio, Inc. (Old), as Director, The Royal College of Physicians, as Member from 1999, Spinal Muscular Atrophy Foundation, as Chief Medical Officer, The Royal College of Paediatrics & Child Health, as Member, and VectivBio Holding AG, as Chief Medical Officer from 2021.
Dr. Khwaja also formerly worked at The Children's Hospital Corp., as Director-Clinical Neurogenetics Program, F.
Hoffmann-La Roche Ltd., as Global Head-Rare Diseases from 2013 to 2019, Roche Pharma (Schweiz) AG, as Global Head-Rare Diseases from 2012 to 2019, and Voyager Therapeutics, Inc., as Chief Medical Officer, Head-Research & Development from 2019 to 2021.
Dr. Khwaja received his doctorate degree from the University of Cambridge.